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Background: Malignant pleural mesothelioma (MPM) is a highly aggressive cancer with a very poor prognosis.
Several clinical studies such as immunotherapy, gene therapy and molecular targeting agents have been tried for
treatment of malignant mesothelioma, however, there is no application for effective clinical treatment. Coffee has
various biological functions such as anti-oxidant, anti-inflammatory, anti-mutagenic and anti-carcinogenic activities.
The therapeutic activities of the bioactive compounds in coffee was sugested to influence intracellular signaling of
MPM. Regarding to the cancer-related functions, In this study, suppression of Sp1 protein level followed by
induction of MSTO-211H cell apoptosis by cafestol and kahweol were investigated in oreder to determine Sp1's
potential as a significant target for human MPM therapy as well.
Methods: Cells were treated separately with final concentration of cafestol and kahweol and the results were
analyzed by MTS assay, DAPI staining, PI staining, luciferase assay, RT-PCR, and immunoblotting.
Results: Viability of MSTO-211H and H28 cells were decreased, and apoptotic cell death was increased in
MSTO-211H as a result of cafestol and kahweol treatment. Cafestol and kahweol increased Sub-G1 population and
nuclear condensation in MSTO-211H cells. Roles of Sp1 in cell proliferation and apoptosis of the MSTO-211H cells by
the Sp1 inhibitor of Mithramycin A were previously confirmed. Cafestol and kahweol significantly suppressed Sp1
protein levels. Kahweol slightly attenuated Sp1 mRNA, while Cafestol did not affect in MSTO-211H cells. Cafestol and
kahweol modulated the promoter activity and protein expression level of the Sp1 regulatory genes including Cyclin
D1, Mcl-1, and Survivin in mesothelioma cells. Apoptosis signaling cascade was activated by cleavages of Bid,
Caspase-3, and PARP with cafestol and by upregulation of Bax, and downregulation of Bcl-xl by kahweol.
Conclusions: Sp1 can be a novel molecular target of cafestol and kahweol in human MPM.
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Cancer is one of the leading causes of death in the world.
Malignant pleural mesothelioma (MPM), the most com-
mon primary tumor of the pleura, is a highly aggressive
cancer with a very poor prognosis. Early detection of
MPM is difficult because of a lack of available tests able to* Correspondence: s1004jh@gmail.com
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reproduction in any medium, provided the oridentify MPM in advance [1,2]. Approximately 80% of
MPM has been associated with respiratory exposure to as-
bestos fibers [3]. Because of the long latent period, the dis-
ease is expected to peak within 20–40 years after the
exposure of asbestos [2]. Survival time of most patients is
very short (median survival of 6–18 months) except in
cases of complete resection [4]. Several clinical trials in-
cluding conventional chemotherapy or radiotherapy were
suggested as a treatment option for MPM, but they did
not present successful therapeutic effectiveness [1]. Further
understanding in mechanisms of mesothelial carcinogenesis. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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against biological pathways especially involved in prolif-
eration, cell survival, and angiogenesis in other cancers
[5]. However, no effective clinical application has been dis-
covered regarding to it yet [6].
Coffee is the most popular beverage in the world after
water, and total transaction regarding to coffee consump-
tion is equal to 10 billion US dollar worldwide. Coffee has
various biological functions regarding to its chemopreven-
tive potential such as anti-oxidant, anti-inflammatory,
anti-mutagenic and anti-carcinogenic activities [7]. Several
researches proved that a daily intake of 2–3 cups of coffee
can be effective against coronary heart diseases, diabetes
mellitus, cancer lines, Parkinson’s, and Alzheimer’s disease
as well. Coffee is a complex mixture of a thousand chemi-
cals containing potential bioactive molecules such as
chlorogenic acid, caffeine, and two diterpenes including
cafestol and kahweol [8]. The typical bean of Coffea arabica
contains cafestol and kahweol, a structural analogue of
cafestol, with individual concentrations ranging from 0.1-
7mg/ml in coffee [9,10]. Cafestol and kahweol are fat-
soluble compounds known as diterpene molecules
(Figure 1A), which are present in oil derived from coffee
beans. Relatively high levels of cafestol and kahweol are
present in unfiltered coffee drinks such as espresso,
French press, boiled coffees or Turkish coffee/Greek cof-
fee, while filtered coffee and instant coffee contain low
levels of cafestol and kahweol [11,12]. The high diterpenes
content, cafestol and kahweol, in coffee is inversely asso-
ciated with reported risk of colorectal cancer [13]. How-
ever, the anti-tumor mechanisms and molecular targets of
cafestol and kahweol are poorly understood, especially in
human malignant pleural mesothelioma.
Specificity protein (Sp) is a transcription factor with
an additional eight family member, and is ubiquitously
expressed in all mammalian cells [14]. Sp1 was recently
defined as the Sp/krűppel-like transcription factor [15]
and has many cellular functions including regulation of
cellular processes, growth, and metastasis of human
tumors by regulating oncogenes, tumor suppressor
genes, cell cycle control molecules, growth-related signal
transductions, angiogenesis-related factors, as well as
apoptosis [16]. Additionally, Sp1 is highly expressed in
various cancers such as breast carcinoma, thyroid can-
cer, hepatocellular carcinoma, pancreatic cancer, colo-
rectal cancer, gastric cancer, and lung cancer [17-20].
Regarding to its cancer-related functions, Sp1 has been
suggested as a novel target for cancer therapy.
Therapeutic activities of the bioactive compounds in
coffee are thought to influence the intracellular signaling
of MPM, although the association between diterpenes
and Sp1signaling has not yet been clarified. In order to
verify its therapeutic potential, we investigated whether
cafestol and kahweol regulated Sp1 target proteins caninduce apoptosis by suppressing Sp1 protein level in
MSTO-211H cells.Methods
Chemicals
Cafestol, Cycloheximide (CHX), and Mithramycin A
(Mith A) were purchased from Sigma-Aldrich (St. Louis,
Missouri). Kahweol was obtained from Santa Cruz Bio-
technology, Inc. (Santa Cruz, CA). The chemicals were
dissolved in dimethyl sulfoxide (DMSO).
Antibodies
The following antibodies were purchased: anti-Cyclin D1
(M-20), anti-Sp1 (1C6), anti-Caspase-3 (H-277),
horseradish-peroxidase-conjugated anti-mouse IgG, and
horseradish-peroxidase-conjugated anti-rabbit IgG (all from
Santa Cruz Biotechnology, Inc.), anti-Poly ADP-ribose
polymerase (PARP) (BD Biosciences, San Diego, California),
anti-Mcl-1, anti-Survivin, anti-Bid, anti-Bax, anti-Bclxl (Cell
Signaling, Danvers, Massachusetts), and anti-β-Actin (AC-
74) (Sigma-Aldrich, Inc. St. Louis, Missouri).
Cell culture
MSTO-211H and H28 cells, a type of human mesotheli-
oma cells, were obtained from the American Tissue Cul-
ture Collection (Manassas, Virginia). The MSTO-211H
cells and H28 were maintained in Hyclone RPMI-1640
containing 5% and 10% fetal bovine serum (FBS), re-
spectively, and 100 U/ml each of penicillin and strepto-
mycin (Thermo scientific, Logan, Utah) at 37°C in a
humidified chamber with 5% CO2 and 95% air. The
medium was changed every two days.
MTS assay
The cell viability of MSTO-211H and H28 cells was
accessed using the MTS (3-(4,5-dimethylthiazol–2-yl)-5-(3–
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H–tetraz-olium)
Assay Kit (Promega, Madison, Wisconsin), according to the
manufacturer’s instruction. The MSTO-211H cells (3×103
cells/100ul/well) or H28 (1.5×103 cells/200 μl) were grown
on a 96-well microtiter plate for 24 hours. Cafestol and kah-
weol were added directly to the culture media with no more
than 0.1% as final concentration of DMSO. Cells were trea-
ted with various concentration of cafestol and kahweol for
24 hours and 48 hours. MTS cell proliferation assay reagent
was added, and samples were incubated at 37°C in 5% CO2
for two hours. Absorbance was measured at 490 nm using
GloMax-Multi Microplate Multimode Reader (Promega,
Madison, Wisconsin), and the difference between the test
and reference wavelength was calculated. The cell viability
was calculated using an equation: (optical density ratio of
cafestol or kahweol-treated sample/non-treated sample)×
100 (%).
Figure 1 The effect of cafestol and kahweol on cell viability in MSTO-211H cells. (A) Chemical structure of cafestol and kahweol. The cell
viability effect of cafestol and kahweol on MSTO-211H (B) or H28 (C) cells. MSTO-211H cells or H28 were treated with cafestol and kahweol in
FBS-RPMI 1640 for various time. The viability of cells were determined with the MTS assay kit, as described under “Material and Methods”. Results
are indicated as cell viability relative to untreated controls with cafestol and kahweol, as determined from three independent experiments. Data
are represented as the mean± SD. The asterisk indicated a significant difference compared with the negative control (p< 0.05). (D) The cell
morphological changes of MSTO-211H cells treated or untreated with cafestol and kahweol for 48 hours.
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Apoptosis of cafestol or kahweol-treated cells was
observed using 4’-6-diamidino-2-phenylindole (DAPI)
staining. Nuclear condensation and fragmentation wereobserved using nucleic acid staining with DAPI (Sigma-
Aldrich, Inc. St. Louis, Missouri). The MSTO-211H cells
treated for 48 hours with 0–90 μM cafestol and 0–60
μM kahweol were harvested by trypsinization, washed
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100% methanol at room temperature for 20 minutes.
The cells were spread on slide, stained with DAPI solu-
tion (2 μg/ml), and observed through a FluoView con-
focal laser microscope (Fluoview FV10i, Olympus
Corporation, Tokyo, Japan).
Propidium iodide staining
After 48 hours of cafestol or kahweol treatment, the
detached cells (floaters) were collected by centrifugation
and combined with adherent cells. The cells were washed
with cold PBS, fixed in 70% ice-cold ethanol overnight at
−20°C, and treated with 150 μg/ml RNase A and 20 μg/ml
propidium iodide (PI; Sigma-Aldrich, Inc. St. Louis,
Missouri). The stained cells were analyzed, and distribu-
tion of the cells in different phases of cell cycle was calcu-
lated using flow cytometry with a MACSQuant Analyzer
(Miltenyi Biotec GmbH, Bergisch Gladbach, Germany).
Reverse transcription-polymerase chain reaction
Total RNA was extracted from cells using TRIzolW Re-
agent (Life Technologies, Carlsbad, California), and first
strand cDNA was synthesized from 2 μg of RNA using
reverse transcriptase with Oligo-(dT) primer according
to instructions for HelixCriptTM 1st-strand cDNA syn-
thesis kit (NanoHelix, Korea). cDNA was obtained by
PCR using β-actin-specific and Sp1-specific primers as
described below under following PCR conditions (25
cycles: 1 min at 95°C, 1 min at 60°C, and 1 min at 72°C).
β-actin primers were: 5'-GTG-GGG-CGC-CCC-AGG-
CAC-CA-3' (forward) and 5'-CTC-CTT-AAT-GTC-
ACG-CAC-GAT-TTC-3' (reverse). Forward Sp1 primers
were: ATG CCT AAT ATT CAG TAT CAA GTA; re-
verse primers were: CCC TGA GGT GAC AGG CTG
TGA. The PCR products were analyzed using 2% agar-
ose gel electrophoresis.
Luciferase Assays
MSTO-211H cells (6 × 104) were seeded into 24 well
plates in triplicate for 24 hrs. Transient transfection was
performed using a LipofectAMINE2000 reagent (Invitro-
gen, Carlsbad, CA, USA). The Survivin-269 promoter
constructs was kindly provided by Dr Sung-Dae Cho
(Chonbuk National University, Jeon-ju, Korea). The mcl-
1 promoter was obtained from Addgene (Cambridge,
MA, USA). Cells were transfected with 250 ng of cyclin
D1 (−1745-luc), mcl-1 (−325), or Survivin (−269), and
20 ng of β-gal using LipofectAMINE2000 reagent (Invi-
trogen, Carlsbad, CA, USA) for 24 h [21]. 48 hrs after
cafestol and kahweol treatment, whole cell lysates were
harvested, and firefly luciferase and galactosidase activity
were determined with a Promega luciferase assay kit
(Madison, WI) according to the manufacturer’s manual.
After PBS wash, passive lysis buffer (200 μl) was added,the cells were then incubated for 1 hr with gentle shak-
ing. Cell lysates (100 μl each) were mixed with 100 μl
luciferase assay reagent, and firefly luciferase light emis-
sion was measured by GloMax™ Multi +MicroplateMulti
Reader (Promega). Subsequently, 50 μl of β-galactosidase
substrate was added in order to normalize the firefly
luciferase data.
Western blotting
The cafestol or kahweol treated cells were cultured for
48 hours and washed twice with cold PBS, then the cells
were lysed with PRO-PREP™ Protein Extraction Solution
(iNtRON Biotechnology, Korea) containing 1 μg/ml
aprotinin, 1 μg/ml leupeptin, and 1 mM PMSF. The
extracted protein was prepared in 200 μl of the extrac-
tion solution, containing about 1 × 107 cells. The protein
concentration was measured using DC Protein Assay Re-
agent (BIO-RAD Laboratories Inc., Hercules, California).
Fifty micrograms of total cellular protein per lane were
separated with 10 and 15% SDS-polyacrylamide gel elec-
trophoresis and transferred onto polyvinylidene difluor-
ide (PVDF) membranes. The membrane was blocked for
two hours at room temperature with 5% non-fat dried
milk in PBS containing 0.1% tween-20, and incubated
with specific antibodies overnight at 4°C. The secondary
antibodies to IgG conjugated with horseradish peroxid-
ase were used, and the membrane was developed with
the Pierce ECL Western Blotting Substrate (Thermo
scientific, Rockford, Illinois) according to the manufac-
turer’s instructions.
Statistical analysis
Data were presented as the mean± SD from three inde-
pendent experiments. Data analysis for statistical signifi-
cance was done using Student’s t-test. Compared to the
vehicle control, p value was less than 0.05, indicating
statistical significance of the data.
Results
Cafestol and kahweol suppress the viability of
mesothelioma cells
To determine the cell viability following treatment with
cafestol and kahweol- 0j, we confirmed the growth
inhibitory potential of MSTO-211H and H28 cells using
the MTS assay. The results indicated that MSTO-211H
and H28 cell viability for 24 and 48 hours was decreased
in cafestol and kahweol dose-dependent as well as time-
dependent manner (Figure 1B). The IC50 value of the
cafestol and kahweol after 48 hrs of incubation was esti-
mated as 82.07 μM and 56.00 μM in MSTO-211H cells
and H28 cells, respectively. Cell viabilities were calcu-
lated as 99.3 ± 1.8%, 75.1 ± 2.6%, and 42.1 ± 2.2% of the
control at 30, 60, and 90 μM cafestol in MSTO-211H
cells and H28 cells, respectively. Kahweol treated cells
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and 42.6 ± 2.6% at 20, 40, and 60 μM. The IC50 of cafes-
tol and kahweol for 48hr treatment in the H28
cells were calculated approximately 62.7 and 57.8 μg/ml
(Figure 1C).
To evaluate the potential cell morphological changes
as a result of treatment with cafestol and kahweol in ma-
lignant mesothelioma cells, MSTO-211H cells were trea-
ted with cafestol (0–90 μM) or kahweol (0–60 μM) of
various concentrations and monitored for 48 hrs. The
MSTO-211H cells was changed to round cell shape, cell
shrinkage was observed, and cell volume was decreased
in those treated with cafestol (60 and 90 μM) and kah-
weol (40 and 60 μM) (Figure 1C).Figure 2 The apoptotic effect induced by cafestol and kahweol in MS
and kahweol (20, 40, and 60 μM) and untreated (DMSO) for 48 hours. The
described in the Methods section. (A) Analysis of DNA fragmentation and n
after cafestol and kahweol treatement in MSTO-211H cells. (B) DNA fragme
triplicates are expressed as the mean± SD. Analysis of cell cycle by flow cy
hours. Representative of Sub-G1 population. The cafestol or kahweol-treate
average of triplicate samples from three independent experiments. The astCafestol and kahweol treatments induce apoptotic cell
death in MSTO-211H cells
The effect of cafestol and kahweol treatment on initi-
ation of apoptosis in MSTO-211H cells was determined
by nuclear morphology using DAPI staining, which
allows visualization of nuclear shrinkage and fragmenta-
tion. Cafestol and kahweol treatment of mesothelioma
cells led to an increase in nuclear condensation and frag-
mentation when compared to control group (Figure 2A, B).
In order to evaluate whether the Sub-G1 population in-
duction by cafestol and kahweol is related to apoptosis,
cafestol and kahweol treated cells were marked with PI
staining. When MSTO-211H cells were treated with cafes-
tol and kahweol, increased number of cells in the Sub-G1TO-211H cells. Cells were incubated with cafestol (30, 60, and 90 μM)
cells were harvested and prepared for DAPI staining and PI staining as
uclear condensation by fluorescence microscopy (magnification X600)
ntation and nuclear condensation were quantified, and the results in
tometry after cafestol (C) and kahweol (D) treatment of cells for 48
d cells were compared with untreated cells, and data are shown as the
erisks (*) indicates p< 0.05 versus control cells.
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MSTO-211H cells and 10 - 31% of kahweol-treated
MSTO-211H cells (Figure 2C, D).
Cafestol and kahweol suppress specificity protein 1
protein in MSTO-211H cells
Numerous studies have documented that the levels of
transcription factor Sp1 expression dramatically
increased during transformation, indicating a critical in-
fluence in tumor development or maintenance. Tran-
scriptional response targeting genes containing Sp1
binding site in their promoters are involved in many cel-
lular functions ranging from differentiation to cell cycle
progression, proliferation and apoptosis [22]. In order to
confirm the Sp1 influence on MSTO-211H cell prolif-
eration, MSTO-211H cells were treated with Mith A, a
known Sp1 inhibitor for 24 and 48 hours. The cells trea-
ted with 10–40 μM Mith A demonstrated decrease in
cell viability (Figure 3A) and induction of nuclear con-
densation and fragmentation (Figure 3B). Sp1 expres-
sion and the expression of Sp1 regulatory proteins
(Cyclin D1, Mcl-1, and Survivin) were significantlyFigure 3 Function of specificity protein 1 on cell viability and protein
mithramycin A (Mith A), a Sp1 regulatory inhibitor. (A) The cell viability effe
cells/200 μl) were treated with Mith A of various concentrations (10–40 μM
effects of Mith A-treated MSTO-211H cells was determined by the MTS assa
fluorescence microscopy (magnification X600) after Mith A treatment in MS
quantified, and the results in triplicate are expressed as the mean± SD. Dat
indicates p< 0.05 versus control cells. (C) The effect of Mith A on the expre
MSTO-211H cells. MSTO-211H cells were treated with Mith A of 20 μM for 4
determined by immunoblotting, as described in the Materials and Methoddownregulated by Mith A as well. In addition, Apoptosis-
related proteins including caspase-3 and PARP were
activated by Mith A (Figure 3C). Regarding to inter-
action with coffee, both cafestol and kahweol sig-
nificantly suppressed Sp1 protein (Figure 4C, D).
However, cafestol did not suppressed Sp1 mRNA
on MSTO-211H cells (Figure 4A), and Kahweol slightly
inhibited Sp1 mRNA (Figure 4B). When CHX-pretreated
MSTO-211H cells were incubated with cafestol and kah-
weol, degradation of Sp1 protein by cafestol and kahweol
was additionally enhanced (Figure 4E, F). Figure 5A, B,
and C showed that cafestol and kahweol clearly attenuated
Cyclin D1, Mcl-1, and Survivin promoter activities.
Cafestol and kahweol also significantly suppressed Cyc-
lin D1, Mcl-1, and Survivin protein levels of expression
(Figure 5D, E).
Cafestol and kahweol regulate the expression of anti-
apoptotic and apoptotic molecules in MSTO-211H cells
Treatment of cells with cafestol and kahweol regulates
the expression levels of various apoptotic proteins.
(Figure 6A, B). Immunoblotting technique was used toexpression of MSTO-211H cells. Sp1 expression is inhibited by
cts of mithrramycin on MSTO-211H cells. MSTO-211H cells (3 × 103
) in 5% FBS-RPMI 1640 for 24 and 48 hours. The cell proliferation
y. (B) Analysis of DNA fragmentation and nuclear condensation by
TO-211H cells. DNA fragmentation and nuclear condensation were
a are indicated from three independent experiments. The asterisks (*)
ssion of Sp1 protein, Sp1 regulatory proteins and apoptotic proteins in
8 hours. The effect of Mith A on Sp1 protein expression levels was
s.
Figure 4 The effect of cafestol and kahweol on Sp1 mRNA and protein expression in MSTO-211H cells. The effect of cafestol (A, 0–90 μM)
and kahweol (B, 0–60 μM) for 48 hours on Sp1 mRNA expression was determined by RT-PCR. The graphs indicate the ratio of Sp1 to β-actin
expression. The effect of cafestol (C) and kahweol (D) for 48 hours on Sp1 protein expression was determined by western blotting. β-actin was
probed to determine the equal loading of protein extract from each treatment. The graphs indicate the ratio of Sp1 to β-actin or Actin
expression. Results are shown as the mean± SD of three independent experiments. The asterisks (*, P< 0.05) indicated a significant change
relative to cafestol or kahweol-treated cells compared with untreated cells. The effect of cafestol (E) and kahweol (F) on Sp1 protein turnover in
MSTO-211H cells. The protein lysates were obtained from cells pretreated with protein synthesis inhibitor such as cyclohexmide (CHX) for 1 hour
and then exposed to cafestol (E) and kahweol (F) for 48 hours. The protein expression of Sp1 were analyzed by western blot analysis.
Lee et al. Journal of Biomedical Science 2012, 19:60 Page 7 of 10
http://www.jbiomedsci.com/content/19/1/60analyze levels of several pro- and anti-apoptotic proteins,
to determine whether treatment with cafestol and kah-
weol regulates expression of apoptosis-related proteins
in MSTO-211H cells. Activation of Bid, Caspase-3, and
PARP, decreased Bcl-xl and increased Bax in cafestol and
kahweol-treated MSTO-211H cells. Inactivated form of
PARP was decreased similarly to that of Sp1.Discussion
Coffee, in the form of roasted coffee beans, is one of the
most widely consumed beverages worldwide. The diter-
penes, cafestol and kahweol, were first identified as the
specific lipidic fraction responsible for the chemopreven-
tive effects of coffee in animal studies. Cafestol and kah-
weol have exhibited numerous beneficial health effects
activities [23-26], however, chemoprotective mechanisms
of cafestol and kahweol are not fully understood.Prognostic determinants of MPM are non-epithelioid
histological subtype, advanced stage, poor performance
status, low hemoglobin level, leucocytosis, and thrombo-
cytosis [27]. In MPM, multimodality treatment including
radiation, surgery, and chemotherapy is used within a
limited group of patients, and response rate of chemo-
therapy application for naïve patients is within 20-40%
due to limited efficacy [28]. Various clinical trials which
have included gene therapy and molecular targeting
agents have consistently been done, although results
from these studies have yet to be applied for clinical
treatment [4,6].
Transcription factor Sp1 is known to be regulated by
molecular target genes in various biological processes
including differentiation, metabolism, cell growth,
angiogenesis and apoptosis [14]. Sp1 is overexpressed in
various human tumors, which may upregulate genes
associated with tumor development, growth, and
Figure 5 The effect of cafestol and kahweol on downstream target proteins by the specificity protein 1 (Sp1). The firefly luciferase Cyclin
D1(A), Mcl-1 (B), or Survivin (C) reporter gene activity was assessed. For the reporter gene assay, MSTO-211H was transfected with a plasmid
mixture containing the Cyclin D1, mcl-1, or survivin luciferase reporter gene (250 ng) and the β-gal gene (20 ng) for normalization. At 24 hours
after transfection, cells were treated with various concentrations of cafestol or kaweol for 48 hours. Results are shown as the mean± SD of
triplicate samples from three independent experiments. The asterisks (*, P< 0.05) indicated a significant change relative to cafestol or
kahweol-treated cells compared with untreated cells. The effect of cafestol (D) and kahweol (E) for 48 hours on Cyclin D1, Mcl-1, and Survivin
was determined by Western blots. Fifty micrograms of cellular extract per lane were separated on the SDS-PAGE gel as described in materials
and methods. Equal loading of protein was confirmed by incubating the same membrane with an anti-β-Actin antibody.
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Thus, Sp1 protein levels are expected to be a negative
prognostic factor and potential therapeutic target for
cancer chemotherapy [29]. Transcriptional factors, such
as NF-κB and AP-1, have previously been identified as
impending targets for therapy in patients with MPM
[30,31]. However, the association between Sp1 and
MPM has not yet been defined. In addition, the pharma-
cological effects of cafestol and kahweol and their in-
volvement in the regulation of the transcriptional
factors have been studied for cancer therapy [32-34],
however, effects of cafestol and kahweol treatment on
human mesothelioma cells have not been reported.
In this study, we focused on whether cafestol and kah-
weol suppressed mesothelioma cell growth (MSTO-
211H and H28) and whether cafestol and kahweol can
inhibit the expression of transcription factor Sp1 and in-
duce apoptotic cell death in MSTO-211H cells. In previ-
ous studies, we confirmed the role of Sp1 in cell
proliferation and apoptosis of MSTO-211H cells by
RNA interference with small interfering Sp1. Our results
confirmed that Mith A induced nuclear condensation
and apoptosis of MSTO-211H cells and inhibited theexpression of Sp1 and Sp1 regulatory proteins. Cafestol
and kahweol inhibited cell viability and induced apop-
totic cell death in MSTO-211H cells. Sp1 could contrib-
ute to cell growth via numerous gene expression
regulation in various cancers [14]. Also, promoters of
many apoptosis-related genes including Bcl-xl, survivin,
Bax, and caspase-3 contain Sp1-binding sites [35]. Cafes-
tol and kahweol inhibit Sp1 protein level and regulate
Sp1 target proteins, such as Cyclin D1, Mcl-1, and Sur-
vivin. Regulation of Sp1 protein level was done via pro-
tein synthesis. We strongly suggest that cafestol
and kahweol suppressed Sp1 protein expression and
down-regulated Sp1-dependent gene expression. Cafes-
tol and kahweol were also involved in apoptosis-related
proteins.
Our results demonstrate Sp1 as an efficient thera-
peutic target of cancer. Sp1 expression levels increase
during transformation, which can play a critical role in
tumor development or maintenance. Although Sp1 de-
regulation is advantageous for treating tumor cells, it is
reported that overexpression of Sp1 induces apoptosis of
untransformed cells or cancer cells. Activation of apop-
totic pathways by Sp1 overexpression is cell type-specific
Figure 6 The effect of cafestol and kahweol on apoptosis of MSTO-211H cells. Fifty micrograms of cellular extract per lane were separated
on an SDS-PAGE gel as described in materials and methods. Immunoblot detection of Bid, Caspase-3, and PARP, upregulation of Bax,
downregulation of Bcl-xl in whole cell lysates from various concentration of cafestol and kahweol-treated MSTO-211H cells for 48 hours. Equal
loading of protein was confirmed by incubating the same membrane with anti-β-Actin antibody.
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transcription level may also occur through indirect
mechanisms by autoregulation of Sp1 [22]. Downregula-
tion of Sp1 for cancer therapy is essential. Cafestol
and kahweol treatment was shown to exhibit cancer
therapeutic effects in MSTO-211H cells. However, defin-
ite verification of the inhibitory mechanisms of cafestol
and kahweol at the molecular pathway of carcinogenesis
is in demand. Cafestol and kahweol may have valuable
chemopreventive effects in non-cancer patients as well
as chemotherapeutic effects in cancer patients. Tumor
necrosis factor-related apoptosis-inducing ligand
(TRAIL) is known as a possible anti-cancer agent, but it
may be inappropriate as a chemotherapeutic agent in
isolation for cancer treatment because of drug resistance
observed in some patients. A combination of kahweol
and TRAIL induces apoptosis in various cancer cells
[37]. This report might explain a role of kahweol as sup-
plemental adjuvant and could present a novel strategy
for cancer therapy. Heterogeneity in the study design of
coffee regarding to gender could account for the differ-
ence in results observed [9]. As other experiments con-
ducted in tumor cell-xenograft animal models, in vivo
studies for MPM are needed to prove the safety and
effectiveness for clinical applications. Cafestol and kah-
weol have similar functions, but they exhibit different
degrees of bioactivity and stability [23,38]. For the most
conventional approach of chemotherapies and chemo-
prevention of cancer, cafestol and kahweol need to be
studied to determine minimum levels required to inhibitincidence of other diseases. Optimal ratio of cafestol and
kahweol for individual for safe and efficient clinical ap-
plication as dietary treatments needs to be determined
as well. Water-soluble properties of cafestol and kahweol
[7] may provide advantages for extraction and absorp-
tion in humans. For elimination of coffee constituents'
side effects, it may be more effective to administer iso-
lated cafestol and kahweol instead of increasing coffee
consumption. Also, since most of consumed coffee is fil-
tered, the idea of administering the extracted cafestol
and kahweol can be very persuasive. Several studies do
not have reported that excess amounts of coffee con-
sumption above 6 cups/day influence the risk of cancer
occurrence [9], however, the risk of other diseases might
be increased by the coffee’s consumptions.
Conclusions
MPM was influenced by the chemotherapeutic effects of
cafestol and kahweol. We suggest that cafestol and kah-
weol regulate Sp1 target proteins, resulting in apoptosis
by the suppression of Sp1 levels in MSTO-211H cells. Sp1
can be used as an effective therapeutic target in cancer
research, and cafestol and kahweol are potential cancer
drugs or adjuvants as chemotherapeutic agents for MPM.
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